At the Cirrhosis Program, part of the University of Michigan’s Hepatology Program, our multidisciplinary team provides chronic disease management support for people with cirrhosis, including structured education on disease self-management, and enrollment in a specialty software program that tracks health maintenance, such as screening for hepatocellular carcinoma (liver cancer).
Medical Services related to Vincent Lingzhi Chen MD
Colon and rectal polyps occur in about 25 percent of men and women ages 50 and older. Not all polyps will turn into cancer, and it may take many years for a polyp to become cancerous. Risk factors include a family history of polyps or colon cancer; an inflammatory bowel disease, such as ulcerative colitis or Crohn’s disease; a high-fat, low-fiber diet; tobacco and alcohol use; little exercise; and obesity.
Digestive health at the University of Michigan Health System diagnoses and treats diseases of the gastrointestinal system of the body, including irritable bowel syndrome, Crohn's Disease, GERD, liver disease and constipation.
At the Viral Hepatitis Program, part of the University of Michigan’s Hepatology Program, we provide the latest diagnostic and treatment options, ready access to new therapies for hepatitis B and C through clinical trials, plus physician assistants and nurse practitioners dedicated to assisting patients receiving standard care with access to medications, monitoring of response, and management of side effects.
Hepatology focuses on the liver, the largest organ inside the body. The liver has many important jobs, including changing food into energy, making bile to help with the digestion of food, and getting rid of toxins from the body. At the University of Michigan Hepatology Program, we diagnose and manage the entire range of liver disease. Our mission is to provide innovative, comprehensive, and compassionate care to patients affected by liver diseases, including liver failure, hepatitis, cirrhosis and fatty liver disease.
Make an appointment with an GI or liver specialist (gastroenterologist or hepatologist) at the University of Michigan or call one of our special clinic phone numbers. Call 1-888-229-7408 to get answers to your questions.
Non-alcoholic fatty liver disease (NAFLD) is a condition of the liver that is characterized by fat accumulation (also known as steatosis) in the liver, occurring in individuals who consume little or no alcohol (equal to or less than two drinks per day in men and one drink per day in women). NAFLD is currently thought to be the most common type of liver disease in both adults and adolescents in the U.S. with rates of up to 25-30% of the U.S. population.
Your gastrointestinal medical care team will depend upon the specific GI condition you are being treated for and often includes doctors with different medical specialties along with other health professionals collaborating to give you the best care possible. This is called a multidisciplinary approach, and at Michigan Medicine, our goal is always to coordinate this multidisciplinary care in a way that is convenient and efficient for you.
Gastroenterology specializes in the diagnosis and treatment of diseases of the gastrointestinal system of the body, which includes the esophagus, stomach, intestines, liver, gall bladder, pancreas, colon and rectum.
Your digestive system is made up of a series of organs that allows your body to get the nutrients and energy it needs from the food we eat. As food travels through the digestive system it is broken down, sorted, and reprocessed before being circulated around the body to nourish and replace cells and supply energy to our muscles. This page includes an animation of the digestive process as well as a description of the various digestive organs and diseases related to them that we treat at the University of Michigan.